We are live on ! Find out more
BNGO icon

Bionano Genomics
BNGO

126 hedge funds and large institutions have $90.6M invested in Bionano Genomics in 2023 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 41 increasing their positions, 33 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

114% more call options, than puts

Call options by funds: $1.6M | Put options by funds: $749K

24% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 33

1.13% less ownership

Funds ownership: 27.81% → 26.68% (-1.1%)

11% less funds holding

Funds holding: 142 → 126 (-16)

25% less capital invested

Capital invested by funds: $121M → $90.6M (-$30.1M)

62% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 26

Holders
126
Holders Change
-16
Holders Change %
-11.27%
% of All Funds
2.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
41
Reduced
33
Closed
26
Calls
$1.6M
Puts
$749K
Net Calls
+$854K
Net Calls Change
-$1.57M

Top Buyers

Rank Fund Capital Flow
1
Nuveen
Nuveen
North Carolina
+$1.2M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$607K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$513K
4
ACS
Archford Capital Strategies
Illinois
+$455K
5
State Street
State Street
Massachusetts
+$394K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$2.1M
2
Millennium Management
Millennium Management
New York
-$1.71M
3
Goldman Sachs
Goldman Sachs
New York
-$632K
4
Morgan Stanley
Morgan Stanley
New York
-$387K
5
Group One Trading
Group One Trading
Illinois
-$299K

BNGO Hedge Fund Activity: Q1 2023 in Review

126 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q1 2023, worth a combined $90.6M — down 25% from $121M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of BNGO and 10 opened new positions — a net loss of 16 holders — while 33 trimmed existing stakes and 41 added.

The largest buyer was Nuveen, adding an estimated $1.2M. The largest seller was Citadel Advisors, cutting an estimated $2.1M.

  • 126 institutional investors held Bionano Genomics (BNGO) as of Q1 2023, down from 142 in Q4 2022.
  • Funds reported $90.6M of Bionano Genomics stock for Q1 2023, down 25% quarter-over-quarter.
  • 10 funds opened new Bionano Genomics positions in Q1 2023 and 26 closed out, a net change of -16 holders.
  • The largest Bionano Genomics buyer in Q1 2023 was Nuveen, an estimated $1.2M added.
  • The largest Bionano Genomics seller in Q1 2023 was Citadel Advisors, an estimated $2.1M sold.

Based on aggregated 13F filings for Q1 2023.